Ecosystem Exchange: Healthtech & Medtech

Ecosystem Exchange: Healthtech & Medtech

28 May, 8:00am - 29 May, 5:00pm

Freeths, 1 Vine Street, London W1J 0AH, | Oxford, United Kingdom

Are you a Nordic health- or medtech startup, scaleup or SME looking to learn more about the UK? Do you want to help turn the life sciences scene more sustainable and grow your business in one of the world’s most forward striving medical markets? The SCC, the Embassy of Sweden in London and the British Embassy Stockholm are proud to present Ecosystem Exchange: Healthtech & Medtech.  

Sweden and the UK is a world leading duo within the area of life sciences, and the bond grew even stronger through the Memorandum of Understanding the two countries signed two years ago. With its ground-breaking research and large investments, the UK offers countless opportunities for businesses looking to expand and explore new markets.  

In a two-day programme, the participating businesses will be introduced to the British ecosystem within health- and medtech, connecting entrepreneurs, stakeholders, investors and industry partners.  

8-12 selected companies will be coached through masterclasses and inspirational speeches, and get the opportunity to meet with important stakeholders in the industry, such as other founders, entrepreneurs and investors – all preparing them to take their business to the next level. Topics to be covered include operational set-up in the UK, the UK marketing and investment landscape, as well as the regulatory environment.  

Last but not least, the companies will partake in a delegation visit to the world-renowned life sciences clusters.  

The programme will: 

  • Help you identify market opportunities, trends and challenges 
  • Increase your understanding for NHS and the life sciences ecosystem
  • Increase your understanding of the regulatory environment and main regulators
  • Explain the UK procurement process and clinical trials  
  • Give valuable insights to the current market outlook for investments in the UK 
  • Help you gain unique insights from seasoned entrepreneurs
  • Provide you with suggestions of useful contacts  
  • Enable your company to be pioneers for a sustainable future 

 

Meet the participating companies

Acorai - Developing a non-invasive intracardiac pressure monitor to improve monitoring and management of >60m heart failure patients worldwide.

AICD - Makes it faster and easier for healthcare professionals to find the right ICD and KVÅ codes

AlgoDX - Developing and implementing clinically validated ML-based clinical decision support software that save lives and reduce costs in healthcare

Arkus AI - Innovate AI to democratize precision medicine and prevention

Avidicare - Design support and customized ventilation solutions for any area where airborne contamination poses a risk to patients or staff

Encare - Supports helthcare providers across the globe to improve patient outcomes and decrease cost in perioperative care by implementing evidence based guidelines from ERAS Society 

Rekonnect - A B2B SaaS vertical solution for Medtech companies to gather commercial intelligence on the use and usability of medical devices

UTI-lizer

UTI-lizer - Develops diagnostic tests for Urinary Tract Infections. We are bringing convenience for patients and cost efficiency to healthcare while fighting antibiotic resistance.

Speakers

Hannah Gibson, Head of Global Partners, Visiba

Hannah Gibson, Head of Global Partners, Visiba
Hannah Gibson is Director of UK & Global Partners at Visiba, a prominent Swedish health tech/AI company. In this capacity, she has led Visiba as the technology partner of NHS England in a ground-breaking project that introduced AI into the front door of NHS urgent care. Hannah also serves as Director of the Digital Health and Care Alliance, a group established by the UK Government to aid health technology adoption.

Johnny McNamara, Invest-ability Investment Readiness Specialist, Newable

Johnny McNamara, Invest-ability Investment Readiness Specialist, Newable
With over 20 years of experience Johnny is an expert in supporting early-stage technology companies to access the capital to grow and scale. His core strength lies in strategic capital raising advice, a critical skillset for navigating the complexities of securing investment. Currently, Johnny is part of the national operational team leading Innovate UK’s flagship investment readiness programme equipping early-stage founders across the UK with the tools, strategies, and guidance to secure investment.

Dr Neil Ebenezer, Medical Technologist and Genomics Specialist, Department for Business and Trade

Dr Neil Ebenezer, Medical Technologist and Genomics Specialist, Department for Business and Trade
Dr Neil Ebenezer has developed a portfolio career. His role at the Department for Business and Trade includes developing and implementing the global strategy for medical technologies and genomics across inward investment and exports. Neil held various posts within the civil service, including; the Department of Health where he contributed to Blood Safety and Genetics policy; was the Head of New and Emerging Technologies at the Medicines & Healthcare Products Regulatory Agency (MHRA).

Dr Ian Newington, Assistant Director, Innovations, LGC

Dr Ian Newington, Assistant Director, Innovations, LGC
Dr Ian is actively involved in the NIHR i4i Programme, managing a portfolio of funded projects and a focus on supporting SMEs wanting funding for Healthtech, signposting them to appropriate support within and outside of NIHR. A career in multinational R&D, most recently GE Healthcare, led to 38 patent applications. I am a Fellow of the Royal Society of Chemistry, a member of UKRI Peer Review College, External Advisory Boards for CPI and NHSE Cancer Programme and mentor for NHS Clinical Entrepreneurs.

Claus Andersen, Partner, Freeths

Claus Andersen, Partner, Freeths
Claus is a partner in Freeths’ corporate group, specialised in assisting European & International businesses with the setting up of their UK operations. Claus’ advice support covers all aspects of corporate and commercial work with a particular focus on mergers and acquisitions, shareholder agreements, joint ventures, licencing agreements and regulatory advice to companies and businesses in the Life Sciences and technology sector.

Ivana Poparic, Head of Life Sciences Cluster Development, MedCity

Ivana Poparic, Head of Life Sciences Cluster Development, MedCity
Ivana is leading MedCity’s cluster development team with focus on life sciences infrastructure and real estate development as well as international relationships to attract more inward investment and research collaborations to London and beyond. Ivana has extensive scientific and commercial expertise and leadership across the innovation pathway for drugs, devices and digital technologies. Her experience includes technology transfer, clinical research, investment, and business development. 

Wael Muselmani, Senior Investment Manager, MedCity

Wael Muselmani, Senior Investment Manager, MedCity
Wael is a member of MedCity Development teams. His 15 years’+ experience includes working in pharma companies, research institutions, and not-for-profit organisations. Wael held various posts in Pharmaceutical sales & marketing, business development, and academic research. With his multidisciplinary scientific background in Pharmacology, Diagnostics, and Molecular Biology, he has been supporting Life Science companies setting up in London and finding the right collaboration and partnership opportunities.

Dr Patrik Bächtiger, Imperial NHS Doctor | NIHR Academic in Digital Health | Venture Partner

Dr Patrik Bächtiger, Imperial NHS Doctor | NIHR Academic in Digital Health | Venture Partner
Patrik looks after adults with acute illness and complex multimorbidity at Imperial NHS Trust. He has an NIHR academic post at Imperial College, where he is an assistant professor in digital health and operates across a large translational research portfolio focused on implementing and scaling technology-enabled clinical pathways. He channels his clinical academic roles and his US/NHS experience into his work with KHP Ventures, the first and only NHS-anchored venture capital fund.

Tim East, Global Health Tech Catalyst | Accelerating Innovation Worldwide | Leading the charge in Accelerator Programs

Tim East, Global Health Tech Catalyst | Accelerating Innovation Worldwide | Leading the charge in Accelerator Programs
Tim has built the Propel programmes into a high value offering to UK and International Health Technology Innovators delivered to over one hundred local and internationally Innovators. Before joining the Health Innovation Yorkshire and Humber organisation, Tim spent over twenty years in the Healthcare sector, delivering innovative solutions into primary and secondary care. With experience and expertese in Product Management, product growth strategies and delivery.

Dominick Kennerson, Senior Vice President for HealthTech, HSBC Innovation Banking London

Dominick Kennerson, Senior Vice President for HealthTech, HSBC Innovation Banking London
Dominick works with the healthtech sector’s leading CEOs and CFOs to solution success via: industry insights, networks, and the bank’s global value proposition. Dominick joined HSBC Innovation Banking in 2023 after a near-decade career with Bayer AG, based in Berlin. With Bayer, he did hold distinct roles, in global communications, global public affairs, and was the Global Director of G4A Digital Health. He is known as a healthcare expert, with deep experience and insight across several sectors.

Johan Aurén, Founder & Managing Director, Accountum

Johan Aurén, Founder & Managing Director, Accountum
Based in London since 1998, Johan gained his qualification as a Chartered Accountant (ICAEW) & Chartered Tax Adviser (CIOT). He founded Accountum Limited in 2009. Johan is a Liveryman and member of the Worshipful Company of Chartered Accountants in England & Wales, a member of the London Chartered Accountants business panel at the Bank of England and the London Chartered Accountants Taxation Committee. He is a Council member of the Anglo Swedish Society and a Trustee of the Swedish Church in London.

Madhav Mahendra, Principal, KHP Ventures

Madhav Mahendra, Principal, KHP Ventures
7 years of experience spanning Venture Capital, Private Equity/Credit, and Asset Management. Madhav is responsible for leading pre-seed, seed, and series-A health/medtech investments at KHP Ventures

Melina Jacovou, CEO & Founder, Propel

Melina Jacovou, CEO & Founder, Propel
Melina is a driven entrepreneur that has helped many tech companies scale both in the UK and Europe. She is a a huge advocate of London and the UK, advising Tech companies on the best approach when expanding, and you may see herspeaking at events talking all things talent, growth and expansion. She works very closely with government bodies to promote the UK as a destination. She is also highly involved in promoting inclusivity.

Elisabeth Parker, Senior Investment Advisor Healthcare and Life Sciences,  Business Sweden

Elisabeth Parker, Senior Investment Advisor Healthcare and Life Sciences, Business Sweden
DrParker has 25 years experience of R&D, partnership building and commercialisation of translational research through licensing and managing spin-out processes. Previously she held business development roles at Macrophage pharma and Cancer Research UK´s development and commercialisation arm and was also the Head of Research at UK quoted KS Biomedix. She currently serves as Non-Executive Director of Hamlet BioPharma and has also served as a Non-Executive Director of Arquer Diagnostics and Azeria Therapeutics

Fredrik Warneryd, Chief Executive, Swedish Chamber of Commerce for the UK

Fredrik Warneryd, Chief Executive, Swedish Chamber of Commerce for the UK
Fredrik Warneryd is the Chief Executive for the Swedish Chamber of Commerce for the UK, one of the largest and most active foreign chambers in the UK. Prior to joining the Chamber, Fredrik held many leading positions in the City of London. With more than 25 years of experience within the Nordic teams of French Banque Paribas, Dresdner Kleinwort Benson, UBS and Credit Suisse, he has earned extensive knowledge and expertise in both the UK and Nordic markets.

Anna Crona, Head of Business Development Services, Swedish Chamber of Commerce for the UK

Anna Crona, Head of Business Development Services, Swedish Chamber of Commerce for the UK
Anna has previously had a successful corporate career at IKEA, building one of the world’s most recognised and admired brands. With an in-depth knowledge of the UK, Anna now works with the establishment and growth of Swedish companies in the UK in her role as Head of the SCC’s Business Development Services Department. Anna was previously on the board of directors for Pen Store AB.

MORE SPEAKERS TBA

MORE SPEAKERS TBA

Register interest to attend

Your details

(If you are an individual member please write 'IM' in this field)

Event Attendees

Attendee

Join our mailing list

and keep up-to-date with the Chamber's news and events.

Read our Privacy Policy here